We report a case of a symptomatic relapse of HIV-related cryptococcal meningoencephalitis eight years after the first diagnosis on the background of immune reconstitution. The findings as well as the clinical course suggests a combination of smouldering localised infection and enhanced inflammatory reaction related to immune restoration due to antiretroviral therapy. A combination of antifungal and anti-inflammatory therapy resulted in clinical and radiological improvement. Our case challenges the concept that immune reconstitution inflammatory syndrome and microbiological relapse are dichotomous entities.
A 40-year-old man with untreated HIV infection was diagnosed with Cryptococcal meningitis in 2006. Serum CRAG titre was 1:1024. The patient was treated for five weeks with liposomal amphotericin B, 5-flucytosine and fluconazole. He recovered completely. Due to poor adherence, he did not take fluconazole secondary prophylaxis and antiretroviral therapy (ART) regularly for the next three years. His CD4 count had fallen to 17 cells/ml (Figure 1(a) ). Beginning in December 2009, the patient became adherent to his ART consisting of tenofovir, emtricitabine and efavirenz. By May 2010, his CD4 had risen to 123 cells/ml (CD4 of 5%) with a viral load of <100 copies/ml. His CD4 count increased up to 272 cells/ml by August 2013 with continuous HIV suppression (Figure 1(a) ).
In January 2014, within three days the patient experienced two focal sensory epileptic seizures affecting the left part of his body. On admission, left-sided distal leg paresis was detected. Cerebral MRI revealed multiple enhancing leptomeningeal and cortical lesions (Figure 1(b) and (c)). CSF analysis showed 24 cells/ml, 90% lymphocytes, protein of 1025 mg/l (normal range: 150-450) with normal lactate and normal glucose. The CSF opening pressure was 190 mm H 2 O. CSF India ink staining and CSF CRAG were negative on three consecutive LPs. Serum CRAG was 1:4. A full microbiological work-up on CSF including fungal cultures was negative.
A follow-up MRI one week later showed progression of the inflammatory lesions. Brain biopsy was performed revealing numerous yeast-like organisms in the subarachnoid space and brain parenchyma surrounded by a fierce inflammatory reaction (Figure 1 (h) and (i)). Budding was detected in a very small fraction of the yeast cells ( Figure 1(h) ). Brain tissue did not grow fungus even after prolonged culture for 28 days. PCR on DNA-extracted brain tissue revealed fungal DNA identified as Cryptococcus spp., based on the ITS2 region of rDNA. The patient was started on liposomal amphotericin B (4 mg/kg/day) and 5-flucytosine (100 mg/kg/day) for two weeks followed by fluconazole 400 mg/day. After two weeks of antifungal treatment, there was a slight improvement in strength of the left lower limb, yet a repeat MRI revealed further progression of the lesions (Figure 1(d) and (e)). Prednisolone (1 mg/kg/day) was added for 10 days with tapering over 7 days. Two weeks later the neurological examination revealed further improvement of muscle strength and MRI showed reduced oedema and reduced contrast enhancement of the lesions (Figure 1(f) and (g) ). On a three-month follow-up, neurological examination revealed normal muscle strength with mild spasticity. Brain MRI showed complete resolution of contrast enhancement and further reduction of lesion size.
Discussion
We describe a case of a patient with a symptomatic relapse eight years after the initial diagnosis of cryptococcal meningitis. The findings and clinical course had features of both paradoxical IRIS and microbiological relapse 1-3 with the brain biopsy demonstrating numerous cryptococcal organisms surrounded by intense CD3 þ CD8 þ T cell inflammation (Table 1 ). Both the brain tissue and CSF did not grow fungus. Lack of growth cannot fully exclude active microbial replication if the fungal CSF burden is low. In our case the lack of growth might also be due to technical issues, because for the first 48 h the tissue was cultured on bacterial media. Alternatively, the immune response may have simultaneously resulted in containment of a slow-growing cryptococcal infection resulting in few viable organisms and negative culture. And yet, the finding of budding yeast cells proves that viable organisms were present in the brain and the meninges. Of note, CSF CRAG was negative despite the high fungal burden on biopsy, again a sign of confinement of the infection to the brain with little antigen shedding into the CSF.
A sterile CSF culture (or appropriately decreased quantitative culture) is diagnostic for cryptococcal IRIS 2 ; however, our case demonstrates that the diagnosis of IRIS must not rely solely on these criteria.
The timing of the symptomatic relapse sheds light on the interplay between infection and inflammation in this disease. Interestingly, the patient did not show any signs or symptoms of a clinical relapse in the first three years following his initial diagnosis of cryptococcal meningitis when his immune system was profoundly suppressed (CD4 <50 cells/ml). The clinical event occurred 40 months after his CD4 counts had increased to over 200 cells/ml (CD4 of 9-16%). This course suggests that an adequate recovery of immune function was required to mount a response to cryptococcal antigen and produce a clinically-evident symptomatic relapse. It also suggests that in the absence of an immune reaction, cryptococci are capable of maintaining a low grade 'smouldering' CNS infection for as long as eight years without producing any clinical symptoms.
In summary, our case illustrates that some cases of symptomatic deterioration of CNS cryptococcosis cannot always be distinctly classified as either microbiologic relapse or IRIS, and may be contributed to by both mechanisms. Combination of antifungal and antiinflammatory treatment might be prudent in such cases of intra-parenchymal involvement.
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Features suggestive of IRIS
Effective ART with undetectable viral load for >30 months. Immune recovery to a CD4 count of 180 cells/ml (14%) at time of the recurrent event from a CD4 nadir of 30 cells/ml (1%). Negative fungal cultures of CSF and brain tissue. Intense inflammation on brain biopsy specimen and MRI. Features suggestive of microbiologic relapse Presence of numerous intact, budding yeasts on brain biopsy eight years after the initial episode. Non-adherence to fluconazole consolidation therapy and secondary prophylaxis.
ART: antiretroviral therapy.
